Cargando…

Associations of viral ribonucleic acid (RNA) shedding patterns with clinical illness and immune responses in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) infection

OBJECTIVES: A wide range of duration of viral RNA shedding in patients infected with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) has been observed. We aimed to investigate factors associated with prolonged and intermittent viral RNA shedding in a retrospective cohort of symptomatic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Pei Hua, Tay, Woo Chiao, Sutjipto, Stephanie, Fong, Siew‐Wai, Ong, Sean Wei Xiang, Wei, Wycliff Enli, Chan, Yi‐Hao, Ling, Li Min, Young, Barnaby E, Toh, Matthias Paul HS, Renia, Laurent, Ng, Lisa FP, Leo, Yee‐Sin, Lye, David C, Lee, Tau Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385430/ https://www.ncbi.nlm.nih.gov/pubmed/32742654 http://dx.doi.org/10.1002/cti2.1160

Ejemplares similares

Safety and potential efficacy of cyclooxygenase‐2 inhibitors in coronavirus disease 2019
por: Ong, Sean Wei Xiang, et al.
Publicado: (2020)

Myeloperoxidase inhibition may protect against endothelial glycocalyx shedding induced by COVID-19 plasma
por: Teo, Andrew, et al.
Publicado: (2023)

Organ‐specific immune response in lethal SARS‐CoV‐2 infection by deep spatial phenotyping
por: Balachander, Akhila, et al.
Publicado: (2022)

Health-seeking behavior of COVID-19 cases during the first eight weeks of the outbreak in Singapore: differences between local community and imported cases and having visits to single or multiple healthcare providers
por: Tay, Min Zhi, et al.
Publicado: (2022)

Real-World Use of Sotrovimab for Pre-Emptive Treatment in High-Risk Hospitalized COVID-19 Patients: An Observational Cross-Sectional Study
por: Ong, Sean W. X., et al.
Publicado: (2022)

Clinical and Virological Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.617.2 (Delta)
por: Ong, Sean Wei Xiang, et al.
Publicado: (2021)

Human neutralising antibodies elicited by SARS‐CoV‐2 non‐D614G variants offer cross‐protection against the SARS‐CoV‐2 D614G variant
por: Lee, Cheryl Yi‐Pin, et al.
Publicado: (2021)

Persistent Symptoms and Association With Inflammatory Cytokine Signatures in Recovered Coronavirus Disease 2019 Patients
por: Ong, Sean Wei Xiang, et al.
Publicado: (2021)

Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity
por: Amrun, Siti Naqiah, et al.
Publicado: (2020)

Viral Ribonucleic Acid Shedding and Transmission Potential of Asymptomatic and Paucisymptomatic Coronavirus Disease 2019 Patients
por: Samaddar, Arghadip, et al.
Publicado: (2020)

External validation of the PRIORITY model in predicting COVID-19 critical illness in vaccinated and unvaccinated patients
por: Ong, Sean Wei Xiang, et al.
Publicado: (2022)

A prospective observational study of the prevalence and risk factors for colonization by antibiotic resistant bacteria in patients at admission to hospital in Singapore
por: Young, Barnaby E, et al.
Publicado: (2014)

Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19
por: Carissimo, Guillaume, et al.
Publicado: (2020)

Effect of Extracellular Ribonucleic Acids on Neurovascularization in Osteoarthritis
por: Qin, Wen‐pin, et al.
Publicado: (2023)

The ribonucleic acids
Publicado: (1977)

Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir
por: Chan, Yi-Hao, et al.
Publicado: (2021)

B-cell ELISpot assay to analyze human memory B cell and plasmablast responses specific to SARS-CoV-2 receptor-binding domain
por: Rouers, Angeline, et al.
Publicado: (2023)

Lack of detail in population-level data impedes analysis of SARS-CoV-2 variants of concern and clinical outcomes
por: Ong, Sean Wei Xiang, et al.
Publicado: (2021)

Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study
por: Young, Barnaby E, et al.
Publicado: (2021)

Resistance of SARS-CoV-2 Delta variant to neutralization by BNT162b2-elicited antibodies in Asians
por: Wang, Bei, et al.
Publicado: (2021)

Asymptomatic COVID‐19: disease tolerance with efficient anti‐viral immunity against SARS‐CoV‐2
por: Chan, Yi‐Hao, et al.
Publicado: (2021)

Absence of contamination of personal protective equipment (PPE) by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
por: Ong, Sean Wei Xiang, et al.
Publicado: (2020)

The Effect of Neonatal Administration of Sex Hormones on Ribonucleic Acid Metabolism in the Liver of Male and Female Rats
por: Toh, Yee-Chu
Publicado: (1971)

Structure of Ribonucleic Acid
por: MARKHAM, ROY, et al.
Publicado: (1951)

Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection
por: Fong, Siew-Wai, et al.
Publicado: (2021)

Response to Letter to the Editor—Viral Ribonucleic Acid Shedding and Transmission Potential of Asymptomatic and Paucisymptomatic Coronavirus Disease 2019 Patients
por: Samaddar, Arghadip, et al.
Publicado: (2021)

Correction to: Robust Virus‐Specific Adaptive Immunity in COVID‐19 Patients with SARS‐CoV‐2 Δ382 Variant Infection
por: Fong, Siew‐Wai, et al.
Publicado: (2021)

Heterologous mRNA vaccine boosters induce a stronger and longer-lasting antibody response against Omicron XBB variant
por: Tay, Matthew Zirui, et al.
Publicado: (2023)

The absolute lymphocyte count accurately estimates CD4 counts in HIV-infected adults with virologic suppression and immune reconstitution
por: Young, Barnaby, et al.
Publicado: (2014)

Antibiotic Therapy in the Treatment of COVID-19 Pneumonia: Who and When?
por: Ng, Tat Ming, et al.
Publicado: (2022)

Derivation and validation of an accurate estimation of CD4 counts from the absolute lymphocyte count in virologically suppressed and immunologically reconstituted HIV infected adults
por: Young, Barnaby, et al.
Publicado: (2015)

Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study
por: Chia, Wan Ni, et al.
Publicado: (2021)

Ribonucleic acid as affected by hepatocarcinogenesis.
por: Dessev, G. N., et al.
Publicado: (1969)

The biological role of ribonucleic acids
por: Brachet, Jean
Publicado: (1960)

Higher Delta variant-specific neutralizing antibodies prevented infection in close contacts vaccinated with ancestral mRNA vaccines during the SARS-CoV-2 Delta wave
por: Goh, Yun Shan, et al.
Publicado: (2023)

Fever Patterns, Cytokine Profiles, and Outcomes in COVID-19
por: Ng, Deborah H L, et al.
Publicado: (2020)

Resistance of SARS-CoV-2 variants to neutralization by convalescent plasma from early COVID-19 outbreak in Singapore
por: Wang, Bei, et al.
Publicado: (2021)

Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients
por: Poh, Chek Meng, et al.
Publicado: (2020)

Dynamic regulation and key roles of ribonucleic acid methylation
por: Zou, Jia, et al.
Publicado: (2022)

Data-Driven Analysis of COVID-19 Reveals Persistent Immune Abnormalities in Convalescent Severe Individuals
por: Lim, Jackwee, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vsmjnqppi48q5cn6it1me93t6o